Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma

Completed · Phase 1/Phase 2

Conditions studied: Lymphoma

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have relapsed or refractory Hodgkin's lymphoma.

Key facts

Study ID
NCT00006029
Run by
Alliance for Clinical Trials in Oncology
People needed
91
Starts
2000-07-01
Expected to finish
2007-02-01
Last updated by the study team
2016-07-14

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.